Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net (loss) income	$ (25,753)	$ (38,496)	$ (50,477)	$ (48,733)	$ (108,664)	$ 9,896
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	5,394	10,933	16,187	21,745	16,686	20,097
Amortization of debt issuance costs	56	112	170	227	1,392	2,591
Amortization of prior hedge effectiveness				0	3,095	3,481
Amortization of right-of-use assets	378	852	1,290	2,049	0	0
Stock-based compensation	21,865	44,712	64,490	80,469	112,596	12,894
Impairment of long-lived assets	0	0	237	248	924	1,105
Impairment of other equity security	170	170	170	3,000	0	0
Impairment of available for sale debt security				0	0	4,818
Loss on debt extinguishment				0	7,955	0
Discontinuance of interest rate swaps and write-off of prior hedge effectiveness				0	8,688	0
Loss on sale of business				0	0	1,764
Deferred income taxes	(1,086)	(2,109)	(2,637)	(793)	(11,595)	1,325
Change in fair value of contingent consideration	0	(150)	(150)	(150)	0	0
Change in fair value of financial guarantee				0	(150)	(1,750)
Change in fair value of derivative instruments				0	392	205
Change in fair value of other equity security				0	(1,812)	0
Unrealized foreign exchange loss (gain)	1,379	3,405	5,958	3,558	943	(1,755)
Other	0	(1)	(1)	168	4	22
Changes in operating assets and liabilities, net of effects of business combinations, asset acquisition and disposal of business:
Accounts receivable	(2,755)	(2,357)	(3,024)	(2,505)	(1,511)	954
Prepaid expenses and other current assets	(6,464)	(417)	(296)	(523)	(4,965)	(799)
Other assets	(811)	(338)	(863)	179	(3,648)	1,153
Accounts payable	(117)	(13,553)	(6,417)	(6,609)	2,360	12,416
Accrued expenses and other liabilities	5,772	6,921	7,585	6,535	13,781	1,418
Operating lease liabilities	(770)	(1,642)	(1,599)	(2,135)	0	0
Income tax payable	7	15	22	28	(185)	10
Deferred revenue	16,472	16,700	21,370	17,079	17,866	23,204
Net cash provided by operating activities	13,737	24,757	52,015	73,837	54,152	93,049
Cash flows from investing activities
Acquisitions, net of cash acquired	0	0	(2,532)	(2,532)	(61,523)	(934)
Asset acquisition, net of cash acquired				6,299	0	0
Proceeds from acquisition working capital adjustment	304	307	307	307	0	0
Purchase of property and equipment	(4,911)	(10,379)	(16,441)	(22,098)	(11,740)	(10,587)
Payment upon extinguishment of interest rate swaps				0	(3,283)	0
Purchase of other equity security				0	(1,127)	0
Sale of business, net of cash sold				0	0	(1,206)
Net cash used in investing activities	(4,607)	(10,072)	(18,666)	(30,622)	(77,673)	(12,727)
Cash flows from financing activities
Repayment of finance and capital lease obligations	(4)			(14)	(31)	(31)
Payment of debt issuance costs				0	(767)	0
Repayment of 2018 Term Loan				0	(524,300)	(5,350)
Proceeds from 2018 Revolving Facility				0	0	40,000
Repayment of 2018 Revolving Facility				0	0	(40,000)
Repayment of hybrid debt				0	(1,332)	(1,249)
Payment upon extinguishment of hybrid debt				0	(9,774)	0
Payment of contingent consideration	0	(600)	(600)	(600)	(1,049)	0
Repurchase and retirement of common stock	(1,094)	(39,155)	(61,736)	(95,126)	0	(4,805)
Tender offer costs				0	0	(145)
Payment of special dividends				0	(112)	(284)
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions				0	581,833	0
Proceeds from private placement, net of underwriting discounts and commissions				0	85,050	0
Payment of stock issuance costs				0	(5,636)	0
Repurchase and retirement of common stock for tax withholding obligations	(11)	(30)	(41)	(41)	(2,342)	(3,606)
Proceeds from issuance of stock under employee stock plans	237	1,487	1,682	2,438	1,819	381
Net cash (used in) provided by financing activities	(872)	(38,298)	(60,695)	(93,343)	123,359	(15,089)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent	(51)	(147)	(139)	(87)	(11)	57
Net (decrease) increase in cash, cash equivalents and restricted cash equivalent	8,207	(23,760)	(27,485)	(50,215)	99,827	65,290
Cash, cash equivalents and restricted cash equivalent, at beginning of the period	239,297	239,297	239,297	239,297	139,470	74,180
Cash, cash equivalents and restricted cash equivalent, at end of the period	247,504	215,537	211,812	189,082	239,297	139,470
Supplemental cash flow data
Interest				0	12,284	27,864
Income taxes				741	1,459	1,485
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets
Cash and cash equivalents	247,504	215,537	211,812	189,082	239,297	114,470
Restricted cash equivalent				0	0	25,000
Total cash, cash equivalents, and restricted cash equivalent shown in the consolidated statements of cash flows	$ 247,504	$ 215,537	$ 211,812	189,082	239,297	139,470
Non-cash investing and financing activities
Right of use assets obtained in exchange for new operating lease liabilities				7,528	0	0
Capitalized stock-based compensation				2,526	674	46
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities				646	676	717
Conversion of Series A redeemable convertible preferred stock into common stock in connection with initial public offering				0	70,906	0
Change in fair value of hedged interest rate swaps and interest rate cap				0	(5,817)	412
Transfer of interest rate swaps derivative liability to hybrid debt				0	0	12,345
Contingent consideration for business acquired				$ 0	$ 0	$ 1,250